1-(6-bromobenzo[d][1,3]dioxol-5-yl)-N-methylpropan-2-amine, monohydrochloride
\n3,4-MDMA (Item No. 13971) is a euphoric entactogen that is regulated as a Schedule I compound in the United States. 6-bromo-MDMA differs structurally from 3,4-MDMA in that it has a bromine group added at the two position of the phenyl ring. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
No Specifications
Please note: Chemical products listed on Novachem's website are for laboratory scientific, industrial and research use only. Products are not for human use or consumption and are not available as therapeutic agents.